These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 3944267)

  • 41. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.
    Breckenridge WC; Little JA; Steiner G; Chow A; Poapst M
    N Engl J Med; 1978 Jun; 298(23):1265-73. PubMed ID: 565877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein C-II deficiency revisited.
    Gotto AM
    N Engl J Med; 1984 Jun; 310(25):1664-5. PubMed ID: 6727938
    [No Abstract]   [Full Text] [Related]  

  • 43. [Plasma lipoproteins and apolipoproteins].
    Reuter W
    Z Gesamte Inn Med; 1979 May; 34(9):241-6. PubMed ID: 225895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives.
    Fellin R; Baggio G; Poli A; Augustin J; Baiocchi MR; Baldo G; Sinigaglia M; Greten H; Crepaldi G
    Atherosclerosis; 1983 Oct; 49(1):55-68. PubMed ID: 6651913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A nonsense mutation in the apolipoprotein C-IIPadova gene in a patient with apolipoprotein C-II deficiency.
    Fojo SS; Lohse P; Parrott C; Baggio G; Gabelli C; Thomas F; Hoffman J; Brewer HB
    J Clin Invest; 1989 Oct; 84(4):1215-9. PubMed ID: 2477392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: a preliminary report.
    Syvänne M; Rosseneu M; Labeur C; Hilden H; Taskinen MR
    Atherosclerosis; 1994 Jan; 105(1):25-34. PubMed ID: 8155085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Density distribution, characterization, and comparative aspects of the major serum lipoproteins in the common marmoset (Callithrix jacchus), a New World primate with potential use in lipoprotein research.
    Chapman MJ; Mc Taggart F; Goldstein S
    Biochemistry; 1979 Nov; 18(23):5096-108. PubMed ID: 227447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Lipid profiles of children and adolescents in Madrid].
    Sánchez Bayle M; González Vergaz A; García Cuartero B; Santos Tapia M; Serna Saugan C; Arias Alvarez MA; García Teresa MA; Merino Arribas JM; Arnaiz Rodríguez P; Baeza Mínguez J
    An Esp Pediatr; 1992 Sep; 37(3):205-10. PubMed ID: 1443916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenesis of type I hyperlipoproteinemia.
    Gnasso A; Koch H; Haberbosch W; Fellin R; Postiglione A; Augustin J
    Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552
    [No Abstract]   [Full Text] [Related]  

  • 50. Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.
    Haberbosch W; Poli A; Baggio G; Fellin R; Gnasso A; Augustin J
    Biochim Biophys Acta; 1984 Mar; 793(1):49-60. PubMed ID: 6704413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
    Wang CS; Alaupovic P; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.
    von Eckardstein A; Funke H; Henke A; Altland K; Benninghoven A; Assmann G
    J Clin Invest; 1989 Dec; 84(6):1722-30. PubMed ID: 2512329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation and characterization of lipoprotein lipase activators from bovine blood serum.
    Sundheim G; Zimmer TL; Astrup HN
    J Dairy Sci; 1983 Mar; 66(3):407-14. PubMed ID: 6841745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catabolism of very low density lipoproteins in experimental nephrosis.
    Garber DW; Gottlieb BA; Marsh JB; Sparks CE
    J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.
    Hazzard WR; Haffner SM; Kushwaha RS; Applebaum-Bowden D; Foster DM
    Metabolism; 1984 Sep; 33(9):779-84. PubMed ID: 6433146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia.
    Hazzard WR; Kushwaha RS; Applebaum-Bowden D; Haffner SM; Steinmetz A; Foster DM
    Metabolism; 1984 Oct; 33(10):873-81. PubMed ID: 6482732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
    Sandholzer C; Feussner G; Brunzell J; Utermann G
    J Clin Invest; 1992 Nov; 90(5):1958-65. PubMed ID: 1430218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.
    Goldberg IJ; Blaner WS; Vanni TM; Moukides M; Ramakrishnan R
    J Clin Invest; 1990 Aug; 86(2):463-73. PubMed ID: 2117022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and metabolic characteristics of an apolipoprotein C-II variant isolated from a hypertriglyceridemic subject.
    Huff MW; Evans AJ; Wolfe BM; Connelly PW; Maguire GF; Strong WL
    J Lipid Res; 1990 Mar; 31(3):385-96. PubMed ID: 2341805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Lipoprotein metabolism in patients with disordered thyroid gland function before and following therapy].
    Rassoul F; Richter V; Kuhlmann E; Heberling HJ; Homann M; Zuck U; Rotzsch W; Lohmann D
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(2):104-11. PubMed ID: 3168898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.